Comparative study of the anticoagulation activity of combined solutions of dihydroquercetin with hyaluronic acid
DOI:
https://doi.org/10.5281/zenodo.8046213Abstract
Introduction. The need for cosmetology procedures grows every year, especially for injection and hardware techniques. In aesthetic correction, among minimally invasive procedures, contour plastic ranks second in popularity after botulinum therapy. One of the most frequent phenomena after injection procedures, which usually do not pose a significant threat, but are aesthetically undesirable, is hemorrhage into soft tissues. Various means are used to eliminate resorption and fading of hematomas: creams, lotions, ointments, etc. Taking into account the literature data on the properties of hyaluronic acid (HA) and a powerful natural antioxidant - the bioflavonoid dihydroquercetin (DHA), we conducted a study on the creation of an injectable drug based on them for a quick effect on subcutaneous hematomas. Materials and methods. The study was carried out in vitro according to the Moravyts method. The object of the study were samples of injection solutions of DHA with HA: - DHA with PVP (Povidone K-17) 5%, pH 7.28; - DHA with HA and L-arginine, pH 7.42. Up to 2 drops of rat blood (approximately 0.1 ml) were applied to the hour glass, no substances were added (intact control), 0.05 ml of physiological solution was added to the blood (control No. 2), 0.05 ml of DHA was added to the blood (experiment 1), 0.05 ml of DHA with HA and L-arginine was added to the blood (experiment 2). The time of coagulation was determined from the moment of the appearance of the first fibrin threads stretching behind the needle. Results and discussion. As a result of the conducted research, it was established that the blood clotting time (intact control) in the absence of its contact with any substance was an average of 3.63 seconds. Addition of saline solution to blood by 35% increased blood clotting time, possibly due to its dilution. Addition of DHA solution with 5% PVP significantly increased blood clotting time by 40.36% compared to saline and almost 2 times compared to the intact control. When adding a DHA solution with HA and L-arginine to the blood, the coagulation time increased significantly - 2.7 times compared to that when adding a physiological solution and 2 times - compared to a DHA solution with 5% PVP. Conclusion. An in vitro comparative study of the anticoagulation activity of combined solutions showed that the combined solution (DHA, HA L-arginine) has the most pronounced effect on hemostasis. The conducted studies are important for the further study of the properties of the composition based on dihydroquercetin, hyaluronic acid and L-arginine.
References
Andre, P., Lowe, N. J., Parc, A., Clerici, T. H., Zimmermann, U. Adverse reactions to dermal fillers: a review of European experiences. J. Cosmetic Laser Ther. 2005. 7. 3-4. P. 171-176.
Zhao, P., Zhao, W., Zhang, K., Lin, H., Zhang, X. Polymeric injectable fillers for cosmetology: current status, future trends, and regulatory perspectives. J. Appl. Polymer Sci. 2020. 137. 25. P.1-14. URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/app.48515
Funt, D., Pavicic, T. Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Clin. cosmetic invest. dermatol. 2013. 295-316. URL: https://www.tandfonline.com/doi/pdf/10.2147/CCID.S50546?needAccess=true&role=button
Klein, A. W. Complications and adverse reactions with the use of botulinum toxin. Disease-A-Month. 2002. 48. 5. H. 336-356.
Lowe, P. L., Patnaik, R., Lowe, N. J. comparison of two botulinum type a toxin preparations for the treatment of glabellar lines: double-blind, randomized, pilot study. Dermatol. Surg. 2013. 31, 12. P. 1651-1654.URL: https://onlinelibrary.wiley.com/doi/abs/10.2310/6350.2005.31303
Zhuchkov, M. V., Bolshakova, E. E., Sonin, D. B., Zhuchkova, U. V. Prevention of hematomas in the induction of injection cosmetology interventions. Vestnik dermatol. venerol. 2018. 94. 6. P. 31-36. URL: http://vestnikdv.ru/jour/article/view/453
Papakonstantinou, E., Roth, M., Karakiulakis, G. Hyaluronic acid: A key molecule in skin aging. Dermato-endocrinol. 2012. 4. 3. P.253-258. URL: https://www.tandfonline.com/loi/kder20
Price, R. D., Berry, M. G., Navsaria, H. A. Hyaluronic acid: the scientific and clinical evidence. J Plastic, Reconstruct. Aesthetic Surg. 2007. 60. 10. P. 1110-1119. URL: https://www.sciencedirect.com/science/article/abs/pii/S1748681507001805
Weidmann, A. E. Dihydroquercetin: More than just an impurity? European J.Pharmacol. 2012. 684. 1-3. P. 19–26. URL: https://www.sciencedirect.com/science/article/abs/pii/S0014299912002956
Farwick, M., Lersch, P., Strutz, G. Low molecular weight hyaluronic acid: its effects on epidermal gene expression & skin ageing. SÖFW J. 2008. 134. 11, P. 2-6. URL:.https://www.xmedicimports.com/shop/images/50kDaHAreport.pdf
Коркунда, С. В., Григорьева, Т. Г. Патогенетические аспекты медикаментозного обеспечения в пластической хирургии. Журн. «Медицина неотложных состояний», 2014. 8 (63). С. 64-73. URL: http://www.mif-ua.com/archive/article_print/39854
Dangoisse, C. Dermo-cosmetics and prevention of skin aging. Rev. Med. Bruxell. 2004. 25. 4. A. 365-370. URL:https://europepmc.org/article/med/15516073
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.